All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Economy

GBCI 2024: South American countries take five spots in the top...

admin
Economy

Global Customized Car Market Size To Exceed Significant Share By 2033...

admin
People

[Latest] Global Functional Mushroom Market Size/Share Worth USD 83,598.7 Million by...

admin
Pr Newswire

Sight Sciences Announces the Release of its First Sustainability Report

admin
Economy

GBCI report: Denmark and the Netherlands confirm their positions amongst the...

admin
Economy

Quality and Compliance Management Course for Virtual Companies (ONLINE: July 11-12,...

admin
Economy

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate...

admin
Economy

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate...

admin
Economy

Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3 –...

admin
Economy

Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3 –...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...